公司代码：600487 公司简称：亨通光电 第一节 重要提示 1.1本半年度报告摘要来自半年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规 划，投资者应当到www.sse.com.cn网站仔细阅读半年度报告全文。 1.2本公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 1.3公司全体董事出席董事会会议。 无 第二节 公司基本情况 2.1公司简介 ■ 2.2主要财务数据 单位：元 币种：人民币 ■ 2.3前10名股东持股情况表 单位: 股 1.4本半年度报告未经审计。 1.5董事会决议通过的本报告期利润分配预案或公积金转增股本预案 ■■ 2.4截至报告期末的优先股股东总数、前10名优先股股东情况表 □适用 √不适用 2.5控股股东或实际控制人变更情况 □适用 √不适用 2.6在半年度报告批准报出日存续的债券情况 □适用 √不适用 第三节 重要事项 公司应当根据重要性原则，说明报告期内公司经营情况的重大变化，以及报告期内发生的对公司经营情 况有重大影响和预计未来会有重大影响的事项 □适用 √ ...

Group 1 - The board of directors of Shanghai Kellytech Medical Technology Co., Ltd. held its tenth meeting of the sixth session on August 19, 2025, with all seven directors present, confirming compliance with relevant laws and regulations [1] - The board approved the 2025 semi-annual report, affirming that it accurately reflects the company's actual situation without any false records or misleading statements [1][2] - The board authorized management to conduct daily related transactions within a projected amount not exceeding 30.55 million yuan (excluding tax) for the year 2025, with a comparison to the previous year's actual transactions [2][3] Group 2 - The expected amount for daily related transactions in 2025 is lower than the actual amount of 43.3 million yuan in 2024, which was 28.77 million yuan, excluding transactions with a related party controlled by a former director [2] - The board's decision regarding the excess portion of related transactions from 2024 was also approved, with a total excess of 3.2441 million yuan noted [3] - The independent directors reviewed and approved the related transaction proposals, ensuring transparency and compliance with regulations [3]

Core Viewpoint - The company plans to increase the expected amount of daily related transactions for 2025, with a total expected amount not exceeding 280,976 million yuan, which includes adjustments for transactions with various related parties [1][2][3]. Summary by Sections Daily Related Transactions Overview - The board of directors approved the proposal for the expected daily related transactions for 2025, with an estimated amount not exceeding 263,700 million yuan, and the proposal was passed at the 2024 annual shareholders' meeting [1][2]. - The company emphasizes that these transactions are normal business operations priced at market rates and will not harm the interests of the company or non-related shareholders [1]. Proposed Increase in Transaction Amounts - The company intends to adjust the expected daily related transaction amount for 2025, estimating a total of 128,331 million yuan for transactions with various related parties [2][3]. - The expected daily related transaction amount from January 1, 2026, until the 2025 annual shareholders' meeting is estimated at 152,645 million yuan [3]. Total Expected Amount - The total expected amount for the proposed increase in daily related transactions is estimated to be 280,976 million yuan, which includes 128,331 million yuan from the date of the shareholders' meeting approval until December 31, 2025 [3][4]. Related Parties Involved - The transactions involve multiple related parties, including but not limited to Hubei Industrial Construction Group Co., Ltd., Hubei Road and Bridge Group Co., Ltd., and Hubei Union Investment City Operation Co., Ltd. [2][3][4]. Approval Process - The proposal for the increase in expected daily related transactions has been reviewed and approved by the board of directors, with related directors abstaining from voting, and it is pending approval from the shareholders' meeting [1][4].

证券代码：300326 证券简称：凯利泰 公告编号：2025-087 上海凯利泰医疗科技股份有限公司 第五届监事会第二十二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完 整，没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 议的通知。 事会。 议监事 1 人（监事卫莉敏女士因个人原因未出席本次会议，也未委托其他监事出 席）。 表决结果：本议案以 2 票同意、0 票反对、0 票弃权获得通过。 《2025 年半年度报告》和《2025 年半年度报告摘要》详见中国证监会指定 的创业板信息披露网站， 《2025 年半年度报告》披露的提示性公告同时刊登于《证 券时报》。 度日常关联交易的议案》 因生产经营需要，公司预计 2025 年度拟与议案中关联公司发生总金额不超 过 3,055 万元（不含税）的销售、采购、租赁物业、咨询服务等日常关联交易， 公司 2024 年度与议案中关联公司的日常关联交易预计金额为人民币 4,330 万元， 实际发生的日常关联交易金额为人民币 2,877.23 万元（公司与原董事、总经理王 正民近亲属控制的上海正佰芮医疗器械有限公司发生的交易除外），2024 年 ...

Core Viewpoint - The company has announced the recognition of excess related party transactions for the year 2024 and the expected related party transactions for the year 2025, with a total amount not exceeding 30.55 million yuan (excluding tax) for 2025 [1][2]. Summary by Sections 1. Basic Information on Related Party Transactions - The company expects to engage in related party transactions totaling no more than 30.55 million yuan for 2025, which includes sales, purchases, property leasing, and consulting services [1]. - The expected amount for related party transactions in 2024 was 43.30 million yuan, with an actual occurrence of 43.64 million yuan, resulting in an excess of 3.24 million yuan [1][2]. 2. Approval Process - The board of directors approved the recognition of excess related party transactions for 2024 and the expected transactions for 2025 with unanimous votes [2][18]. - The management is authorized to conduct daily transactions within the specified amount, and any excess will require further board or shareholder approval [2][18]. 3. Expected Related Party Transaction Categories and Amounts - The expected categories for 2025 include: - Rental of properties from Shanghai Ligetai: 3.80 million yuan - Rental of properties from Ligetai Equipment: 2.80 million yuan - Rental of properties from Shanghai Yijutai: 1.60 million yuan - Sales of goods to Shanghai Ligetai: 1.00 million yuan - Sales of goods to Tianjin Kangernuo: 0.50 million yuan - Consulting services from Shanghai Yueling: 1.00 million yuan - Total expected transactions amount to 30.55 million yuan [1][3][4]. 4. Previous Year’s Related Party Transactions - The actual occurrence of related party transactions for 2024 was 43.64 million yuan, with significant categories including: - Rental from Shanghai Ligetai: 3.67 million yuan - Rental from Ligetai Equipment: 2.56 million yuan - Purchases from Shanghai Yijutai: 6.43 million yuan - Total actual transactions were 28.77 million yuan [4][5]. 5. Related Party Information - Shanghai Ligetai has a registered capital of 65.50 million yuan and reported total assets of 468.78 million yuan as of December 31, 2024 [6][7]. - Ligetai Equipment has a registered capital of 6.88 million yuan and reported total assets of 47.21 million yuan as of December 31, 2024 [8]. - Shanghai Yijutai has a registered capital of 40 million yuan and reported total assets of 25.98 million yuan as of December 31, 2024 [9]. 6. Impact and Purpose of Related Party Transactions - The related party transactions are necessary for the company's normal production and operations, conducted on fair and voluntary terms, and do not harm the interests of the company or its shareholders [17][18]. - The transactions are expected to support the company's stable development and will not affect its independence [17][18].

Meeting Overview - The board meeting was held on August 25, 2025, in Dongying City, Shandong Province, with all 9 directors present and voting [1][2] - The meeting was chaired by Chairman Guo Tianming [1] Resolutions Passed - Approval of the establishment of a special account for raised funds and authorization for signing the fund supervision agreement [2] - Approval to increase the estimated amount for daily related party transactions by 35 million yuan [2][3] - Approval of the 2025 semi-annual report and its summary [4][5] - Approval of the revision of the "Fund Management Measures" [5] - Approval to convene the fourth extraordinary general meeting of shareholders in 2025 [5] Fund Management - The company plans to open a special account for raised funds in compliance with relevant laws and regulations, ensuring dedicated management of the funds [2] - The board authorized the legal representative or authorized person to handle the establishment of the special account and related agreements [2] Related Party Transactions - The increase in the estimated amount for daily related party transactions was deemed necessary for the company's operational needs, with fair pricing and no harm to the interests of the company or minority shareholders [3] Financial Reporting - The audit committee confirmed that the semi-annual report and its summary contained no false records or misleading statements [4]

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to discuss key proposals, including the employee stock ownership plan and daily related transactions [1][4][8] Group 1: Meeting Details - The meeting is scheduled for September 4, 2025, at 14:30, located at the company's office in Chongqing [4] - The meeting will be conducted both in-person and online, with specific voting times outlined for shareholders [4] - The agenda includes the introduction of attendees, discussion of proposals, and voting on the resolutions [4][8] Group 2: Proposal on Employee Stock Ownership Plan - The company proposes to repurchase and cancel 1,715,024 shares from the 2024 employee stock ownership plan due to unmet performance conditions [8][10] - The repurchase price is set at 8.23 yuan per share, adjusted from the original price of 12.27 yuan per share [10][11] - The funding for the repurchase will come from the company's own funds, and the cancellation will not affect the control of the company [11][12] Group 3: Daily Related Transactions - The company plans to increase the expected amount for daily related transactions in 2025, with a total expected amount of 5,990 million yuan [6][8] - The increase is primarily due to the need to meet procurement demands from related parties [6][7] - The transactions will adhere to fair market pricing principles and will not harm the interests of shareholders [7][8]

Core Points - The company held its ninth board meeting on August 25, 2025, to discuss various proposals, including the approval of the 2025 semi-annual report [1] - The board approved an additional expected daily related party transaction amounting to 35.9 million yuan for graphite processing services and 40.06 million yuan for purchasing ink and glaze materials [2] - The company revised several corporate governance systems in accordance with relevant laws and regulations, with all proposals receiving unanimous approval from the board [3][4] Summary by Category Financial Reporting - The board approved the 2025 semi-annual report and summary, with a voting result of 10 in favor, 0 against, and 0 abstentions [1] Related Party Transactions - The company agreed to increase expected daily related party transactions for 2025, including 35.9 million yuan for services from a subsidiary of Guangdong Hongyu Group and 40.06 million yuan for materials from Shandong Guoci Kanglitai New Materials Technology Co., Ltd. [2] Corporate Governance - The company revised several governance systems, with all amendments receiving unanimous approval from the board, indicating a commitment to compliance and best practices [3][4]

中信建投证券股份有限公司 关于爱迪特（秦皇岛）科技股份有限公司 增加2025年度日常关联交易预计额度的核查意见 中信建投证券股份有限公司（以下简称"中信建投"、"保荐人"）作为爱迪特 （秦皇岛）科技股份有限公司（以下简称"爱迪特"、"公司"）首次公开发行股票 的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交易所上市公司 自律监管指引第13号——保荐业务》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运作》等相 关规定，对爱迪特增加2025年度日常关联交易预计额度的事项进行了审慎核查， 具体情况如下： 一、日常关联交易基本情况 （一）日常关联交易概述 第十九次会议，审议通过了《关于 2025 年度日常关联交易预计的议案》，预计公司 及控股子公司 2025 年度与相关关联方可能发生的日常关联交易总金额为不超过人民 币 8,500.00 万元（不含税）。具体内容详见公司于 2025 年 4 月 29 日披露的《关于 等相关法律法规、规范性文件及《公司章程》有关规定，基于公司及子公司业务发 展及日常经营需要，公司预计增加与关联方景德镇万微新材料有限公司 ...

证券代码：002785 证券简称：万里石 公告编号：2025-041 厦门万里石股份有限公司 第五届董事会第二十三次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、 董事会会议召开情况 厦门万里石股份有限公司（以下简称"公司"）第五届董事会第二十三次会 议于 2025 年 8 月 15 日以邮件和通讯方式发出会议通知，并于 2025 年 8 月 22 日在厦门市思明区湖滨北路 201 号宏业大厦 8 楼公司大会议室以现场结合通讯的 方式召开临时会议。会议应出席董事为 6 人，实际出席董事 5 人（其中董事长胡 精沛先生委托副董事长邹鹏先生表决），本次会议由副董事长邹鹏先生主持，公 司监事、高级管理人员列席了会议，会议的召集和召开符合《中华人民共和国公 司法》和《公司章程》的有关规定，所做决议合法有效。经表决，会议审议通过 议案情况如下： 公司根据实际经营发展需要，拟新增日常关联交易预计，具体如下：新增与 关联公司厦门资生环保科技有限公司（以下简称"资生环保"）签署《业务合作 框架性协议》，预计发生的日常关联交易总额不超过 2,500 万元；新 ...